Last reviewed · How we verify

NCT04591145

Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System

Status unknown Last updated 19 October 2020
What this trial tests

trial testing Observational group in Adenoma in 1,400 participants. Status unknown.

Timeline
9 October 2020
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorRenmin Hospital of Wuhan University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,400
Start date9 October 2020
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Renmin Hospital of Wuhan University

Who can join

18 and older, any sex, with Adenoma or Bowel Preparation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A deep learning based system to calculate the proportion of Boston Bowel Prep Scale (BBPS) score of 0-1 during withdrawal phase has been constructed previously. This multi-center study is going to perform a prospective observational study to validate the threshold of the adequate proportion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational group

Trials testing the same drug.

Other recruiting trials for Adenoma

Currently open trials in the same condition.

Other Renmin Hospital of Wuhan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04591145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing